Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT02349841 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098

Phase: N/A Priority: Normal
NCT ID: NCT05473195 Org: User:
Start: 12/06/22 End: 04/16/24 Due: 04/16/25

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Phase: N/A Priority: Normal
NCT ID: NCT06748937 Org: User:
Start: 03/03/25 End: 03/30/26 Due: 03/30/27

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB

Phase: N/A Priority: Normal
NCT ID: NCT04629378 Org: User:
Start: 08/17/20 End: 06/04/21 Due: 06/04/22

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04379336 Org: User:
Start: 05/04/20 End: 01/02/22 Due: 01/02/23

Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT05896930 Org: User:
Start: 11/09/17 End: 01/04/21 Due: 01/04/22

EBA, Safety and Tolerability of Sanfetrinem Cilexetil

Phase: N/A Priority: Normal
NCT ID: NCT05388448 Org: User:
Start: 04/21/22 End: 08/19/24 Due: 08/19/25